Method of treating cancerous cachexia in humans with hydrazine sulfate
US4110437A · kind A · utility
1Cited by
0References
6Claims
0Family size
Inventor
Key dates
| Filing date | Feb 3, 1977 |
| Grant date | Aug 29, 1978 |
| Priority date | — |
| Expiry date | Feb 3, 1997 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K33/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Hydrazine sulfate alone or formulated with liquid or solid carriers will retard and reduce cancerous cachexia even in the absence of tumor reduction when administered to humans either orally or parenterally.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.